Skip to main content

letter

. 1991 Feb;31(2):211–213. doi: 10.1111/j.1365-2125.1991.tb05521.x

Pharmacological activity of the dinitrate metabolites of nitroglycerin following their oral administration to healthy volunteers.

M Gumbleton, L Z Benet

PMCID: PMC1368399 PMID: 1904752

211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Davidov M. E., Mroczek W. J. Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity: a double-blind evaluation. Angiology. 1977 Mar;28(3):181–189. doi: 10.1177/000331977702800306. [DOI] [PubMed] [Google Scholar]
Nakashima E., Rigod J. F., Lin E. T., Benet L. Z. Pharmacokinetics of nitroglycerin and its dinitrate metabolites over a thirtyfold range of oral doses. Clin Pharmacol Ther. 1990 May;47(5):592–598. doi: 10.1038/clpt.1990.80. [DOI] [PubMed] [Google Scholar]
Noonan P. K., Benet L. Z. The bioavailability of oral nitroglycerin. J Pharm Sci. 1986 Mar;75(3):241–243. doi: 10.1002/jps.2600750306. [DOI] [PubMed] [Google Scholar]
Noonan P. K., Benet L. Z. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration. Clin Pharmacol Ther. 1987 Sep;42(3):273–277. doi: 10.1038/clpt.1987.146. [DOI] [PubMed] [Google Scholar]
Winsor T., Berger H. J. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design. Am Heart J. 1975 Nov;90(5):611–626. doi: 10.1016/0002-8703(75)90226-4. [DOI] [PubMed] [Google Scholar]
Yu D. K., Williams R. L., Benet L. Z., Lin E. T., Giesing D. H. Pharmacokinetics of nitroglycerin and metabolites in humans following oral dosing. Biopharm Drug Dispos. 1988 Nov-Dec;9(6):557–565. doi: 10.1002/bod.2510090606. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES